Quaker Houghton (KWR) reported a solid fourth quarter for 2025, with net sales increasing 6% year-over-year to $468.5 million. Growth was primarily driven by strategic acquisitions, including Dipsol, and favorable currency translation, which offset a slight decline in organic volumes. The company saw significant margin improvement, with non-GAAP earnings per diluted share rising 24% to $1.65 and adjusted EBITDA growing 11% to $71.9 million.

Quaker Houghton delivered strong third quarter 2025 results, with net sales increasing 7% year-over-year to $493.8 million, primarily due to a 3% increase in organic sales volumes and a 5% contribution from acquisitions. Adjusted EBITDA rose 5% to $82.9 million, and non-GAAP earnings per diluted share increased 10% to $2.08.

Quaker Chemical experienced a challenging second quarter in 2025, reporting a net loss of $66.6 million, primarily due to an $88.8 million goodwill impairment charge related to its EMEA segment. Despite this, the company saw a 4% increase in net sales to $483.4 million, driven by a 6% contribution from acquisitions and 2% organic sales volume growth. Adjusted EBITDA decreased by approximately 10% year-over-year to $75.5 million, reflecting lower operating margins.

Quaker Houghton reported a decline in net sales and net income in Q1 2025 compared to the prior year, primarily due to lower sales volumes, unfavorable foreign currency translation, and decreased selling prices and product mix. Despite the decline, results improved compared to the prior quarter, driven by share gains, improved margins, and cost optimization actions. The company also completed several strategic acquisitions to enhance its portfolio and accelerate growth.

Quaker Houghton's Q4 2024 performance saw a 5% decrease in net sales to $444.1 million and a decline in net income to $14.2 million. Despite a challenging macro environment, the company improved profitability and generated strong cash flow for the full year, driven by new business wins, particularly in Asia/Pacific.

Quaker Houghton reported Q3 2024 net sales of $462.3 million, a 6% decrease compared to Q3 2023. Net income was $32.3 million, or $1.81 per diluted share. Non-GAAP net income was $34.0 million, or $1.89 per diluted share. The company generated adjusted EBITDA of $78.6 million with a margin of 17.0%.

Quaker Houghton reported a decrease in net sales by 6% to $463.6 million, primarily due to lower selling prices, product mix, and sales volumes. Despite the revenue decline, the company increased net income to $34.9 million, or $1.94 per diluted share, and non-GAAP earnings to $2.13 per diluted share. Adjusted EBITDA rose by 5% to $84.3 million, driven by improved gross margins.

Quaker Houghton announced its first quarter 2024 results with net sales of $469.8 million, net income of $35.2 million, and EPS of $1.95. The company's adjusted EBITDA increased by 6% compared to the prior year, driven by improved gross margins. Despite a decline in sales volumes and selling price/product mix, the company remains confident in delivering volume and earnings growth in 2024.

Quaker Houghton reported Q4 2023 net sales of $467.1 million and net income of $20.2 million, or $1.12 per diluted share. Non-GAAP net income was $31.9 million, or $1.78 per diluted share. Adjusted EBITDA increased by 13% year-over-year to $77.0 million.

Quaker Houghton reported Q3 2023 net sales of $490.6 million, net income of $33.7 million, and EPS of $1.87. Non-GAAP net income was $36.9 million, with non-GAAP EPS at $2.05. Adjusted EBITDA increased by 20% to $84.4 million, and the company generated $199.5 million in operating cash flow year-to-date.

Quaker Houghton reported a 1% increase in net sales to $495.4 million, driven by value-based pricing. Net income rose to $29.3 million, or $1.63 per diluted share, while adjusted EBITDA increased by 37% to $80.2 million.

Quaker Houghton announced record net sales of $500.1 million for Q1 2023, a 5% increase compared to Q1 2022. The company reported net income of $29.5 million, or $1.64 per diluted share, and non-GAAP earnings per diluted share of $1.89. Adjusted EBITDA increased by 30% to $78.8 million, driven by higher net sales and improved gross margins.

Quaker Houghton's Q4 2022 net sales increased by 8% to $484.8 million compared to Q4 2021, driven by higher selling prices. The company reported a net loss of $76.0 million, or $4.24 per diluted share, which includes a $93.0 million impairment charge. Non-GAAP net income was $25.0 million, or $1.39 per diluted share, and adjusted EBITDA increased by 12% to $67.9 million.

Quaker Houghton reported a net sales increase of 10% in Q3 2022, driven by pricing actions and acquisitions, despite volume declines due to softer market conditions, particularly in Europe and Asia/Pacific. The company's net income was $25.9 million, or $1.44 per diluted share, while non-GAAP earnings per diluted share were $1.74. Adjusted EBITDA increased by 6% to $70.3 million.

Quaker Houghton reported record net sales of $492.4 million for Q2 2022, a 13% increase compared to the prior year. However, net income decreased to $14.3 million, or $0.80 per diluted share, compared to $33.6 million, or $1.88 per diluted share in the prior year, primarily due to lower gross margins attributable to significant increases in raw material and other costs.

Quaker Houghton reported record net sales of $474.2 million in Q1 2022, a 10% increase year-over-year. This growth was primarily due to higher selling prices and product mix, as well as contributions from acquisitions. However, net income decreased to $19.8 million, or $1.11 per diluted share, due to lower gross margins resulting from significant increases in raw material and other costs.

Quaker Houghton reported a 16% increase in net sales to $447.0 million for Q4 2021, driven by price increases and acquisitions. However, net income decreased to $18.1 million, or $1.01 per diluted share, and adjusted EBITDA fell by 7% to $60.7 million due to rising raw material costs and supply chain pressures.

Quaker Houghton reported a 22% increase in net sales to $449.1 million driven by higher sales volumes, price increases, and favorable foreign currency translation. Net income increased to $31.1 million, or $1.73 per diluted share. The company experienced challenges from escalating raw material costs, which negatively impacted gross margins.

Quaker Houghton reported a strong second quarter with a 52% increase in net sales and a significant improvement in net income compared to the prior year. The company benefited from higher sales volumes, cost synergies, and market share gains, but faced challenges from rising raw material costs and supply chain issues.

Quaker Houghton reported a strong first quarter with net sales increasing by 14% to $429.8 million, driven by higher volumes and the positive impact of foreign currency translation. Net income was $38.6 million, or $2.15 per diluted share, compared to a net loss in the prior year, with non-GAAP earnings per diluted share at $2.11. Adjusted EBITDA increased by 28% to $77.1 million due to higher net sales and cost synergies from the Combination.

Quaker Houghton reported fourth-quarter net sales of $385.9 million, a 1% decrease compared to the prior year, but net income increased to $48.5 million. The adjusted EBITDA grew 8% due to cost synergies. The company anticipates a step change in profitability for 2021.

Quaker Houghton's Q3 2020 results showed a strong rebound compared to Q2, with net sales at $367.2 million, a 13% increase year-over-year. Net income was $27.3 million, and adjusted EBITDA increased 24% to $63.9 million year-over-year. The company expects gradual sequential improvement in markets and anticipates full-year adjusted EBITDA to exceed $215 million.

Quaker Houghton reported a challenging second quarter in 2020, with a net loss of $7.7 million due to the impact of COVID-19 on global industrial production. Net sales increased 39% year-over-year to $286.0 million, driven by the Houghton and Norman Hay acquisitions, but declined 27% compared to prior year pro forma net sales. Despite the challenges, the company generated cash, reduced net debt, and realized integration cost savings.

Quaker Houghton reported a 79% increase in net sales to $378.6 million compared to the prior year, driven by the Houghton and Norman Hay acquisitions. However, the company experienced a net loss of $28.4 million, primarily due to a non-cash impairment charge and a settlement charge related to the termination of a U.S. defined benefit pension plan.

Quaker Houghton reported Q4 2019 net sales of $391.3 million, an 85% increase compared to the prior year, driven by the Houghton and Norman Hay acquisitions. Net income was $15.2 million, or $0.86 per diluted share. Non-GAAP earnings per diluted share were $1.34. Adjusted EBITDA was $60.6 million, up 4% on a pro forma basis.